Tech Company Financing Transactions
PellePharm Funding Round
On 11/21/2018, PellePharm raised $70 million in funding from LEO Pharma.
Transaction Overview
Company Name
Announced On
11/21/2018
Transaction Type
Venture Equity
Amount
$70,000,000
Round
Undisclosed
Investors
LEO Pharma (Thorsten Thormann)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
101 Mission St. 2050
San Francisco, CA 94105
USA
San Francisco, CA 94105
USA
Phone
Website
Email Address
Overview
PellePharm leads the way in applying precision medicine to dermatology. PellePharm is a biotechnology company committed to targeting rare dermatologic diseases at the source.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sanuj Ravindran
Chief Medical Officer
Ervin Epstein
VP - Operations
David Hinds
VP - Operations
Gerd Kochendoerfer
VP - Regulatory Affairs
Alix Alderman
Browse more venture capital transactions:
Prev: 11/21/2018: Neurelis venture capital transaction
Next: 11/21/2018: SysAid venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to document every notable VC transaction. All VC database entries on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs